Do not stop using these drugs without first consulting with your physician.
Abilify® Gambling Addiction Lawsuits
In May 2016, the FDA issued an official warning about impulse-control problems related to use of the drug Abilify®.
"The U.S. Food and Drug Administration (FDA) is warning that compulsive or uncontrollable urges to gamble, binge eat, shop, and have sex have been reported with the use of the antipsychotic drug aripiprazole (Abilify®, Abilify Maintena®, Aristada, and generics)."
FDA Safety Alerts
Patients and caregivers should be on alert for uncontrollable and excessive urges and behaviors while taking aripiprazole.
These after-effects of Abilify® were enough to warrant multiple lawsuits filed against Bristol-Myers Squibb and Otsuka America Pharmaceuticals for failing to list all possible side effects of the drug.
Abilify® lawsuits have been filed against the Abilify® manufacturers by both patients and their families seeking compensation for injuries, including the severe emotional damage caused by this drug and these side effects.
Doctors issue 8.7 MILLION prescriptions of Abilify® a year, and this number is growing.
Abilify® Settlement Amounts, Compensation and Victim Payouts
Abilify® is an antipsychotic drug with a list of devastating side effects, that manufacturers failed to properly warn the public of in a timely manner.
The U.S. Food and Drug Administration (FDA) initially approved Abilify® in 2002 as a treatment for schizophrenia.
The first Abilify® related settlement was for $515,000,000 and was finalized in 2007 between Bristol-Myers Squibb and the U.S. Justice Department.

Multiple Abilify® Lawsuits are currently being filed against Bristol-Myers Squibb for failing to disclose the compulsive behaviors as a possible side effect of Abilify®, and settlement amounts for Abilify® lawsuits are likely to be substantial.

Compulsive and often addictive behaviors caused by Abilify® include:
- Overeating and weight gain
- Stealing
- Hypersexuality
- Pathological gambling
- Excessive shopping